Lay opinion vs evidence: MTHFR Check

MTHFR (methylenetetrahydrofolate reductase) is an enzyme involved in converting folate into its active form. Variants like C677T (rs1801133) are very common – about 30–40% of the population carry at least one copy. In lay opinion, MTHFR is often portrayed as a 'master regulator' of methylation, supposedly influencing everything from depression to cancer to chronic disease. However, the scientific evidence is much weaker: while a link to elevated homocysteine levels is well-established, the clinical relevance for most people is low. Methylation is influenced by many genes, nutrients, and environmental factors; a single SNP explains only a small fraction of the variance. Direct-to-consumer tests tend to exaggerate the significance and often create unnecessary anxiety. There is no robust evidence that MTHFR variants alone cause serious illness or that special supplements (e.g., methylfolate) are necessary for all carriers. A balanced diet rich in folate (leafy greens, legumes) is usually sufficient. Caution is advised against expensive personalized supplements without medical supervision. Homocysteine testing may be useful in specific clinical contexts. Bottom line: MTHFR is an interesting but overhyped marker – the evidence does not support broad application outside specific clinical questions.